Point72 Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Point72 Asset Management's NVS Position: Q1 2026 in Review
Point72 Asset Management opened a new position in Novartis (NVS) in Q1 2026: 283,837 shares worth $43.4M. The stake represents 0.06% of the portfolio and ranks #432 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in NVS as recently as Q2 2025.
Point72 Asset Management first reported a position in NVS in Q2 2014 and has held it in 22 quarters since. The position peaked at $167M in Q1 2023. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Point72 Asset Management held 283,837 shares of Novartis worth $43.4M as of Q1 2026.
- Novartis was a new Point72 Asset Management position in Q1 2026.
- Novartis made up 0.06% of Point72 Asset Management's portfolio in Q1 2026, its #432 holding.
- Point72 Asset Management first reported a position in Novartis in Q2 2014 and has held it in 22 quarters since.
- Point72 Asset Management's Novartis position peaked at $167M in Q1 2023.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.